Flash | 21 Jan 2026 12:02:50 ET │ 11 pages MicroPort MedBot (2252.HK) FY25 Profit Alert with Strong Topline Growth; Landmark Policy Unlocks Commercialization; Reiterate Buy CITI'S TAKE MicroPort MedBot issued a strong positive profit alert for FY25, guiding for revenue growth of 110-120% YoY, beating our 100% estimate and VA consensus of 94%. The adjusted net loss is guided to narrow by more than 50%, in line with expectations. We view the topline beat as the key takeaway, as it confirms the company is in a ...